Overview

Tafenoquine and DHA-piperaquine (TADORE- Plus)

Status:
NOT_YET_RECRUITING

Trial end date:
2027-12-01

Target enrollment:

Participant gender:

Summary

A trial designed to determine whether there is a clinically significant drug-drug interaction of tafenoquine with DHA-piperaquine using a control arm with radical cure given at the end of follow up (delayed radical cure).

Phase:

PHASE4

Details

Lead Sponsor:

Menzies School of Health Research

Treatments:

tafenoquine